Ursodeoxycholic acid for primary biliary cirrhosis

Drug and Therapeutics Bulletin

Volumn 37, Issue 4, 1999, Pages 30-32

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CLOFIBRATE; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; METHOTREXATE; PENICILLAMINE; URSODEOXYCHOLIC ACID;

CLINICAL TRIAL; DIARRHEA; DRUG COST; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PRIMARY BILIARY CIRRHOSIS; SHORT SURVEY;

EID: 0033368655     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.1999.37430     Document Type: Short Survey

References (24)

1. Metcalf J, James O. The geoepidemiology of primary biliary cirrhosis. Semin Liver Dis 1997; 17: 13-22.
2. Gershwin ME, Mackay IR. Primary biliary cirrhosis: paradigm or paradox for autoimmunity. Gastroenterology 1991; 100: 822-33.
3. Neuberger J. Primary biliary cirrhosis. Lancet 1997; 350: 875-9.
4. Nyberg A, Lööf L. Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease. Scand J Gastroenterol 1989; 24: 57-64.
5. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996; 335: 1570-80.
6. Wiesner RH, Ludwig J, Lindor KD et al. A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. N Engl J Med 1990; 322: 1419-24.
7. Kaplan MM, Knox TA. Treatment of primary biliary cirrhosis with low-dose weekly methotrexate. Gastroenterology 1991; 101: 1332-8.
8. Sharma A, Provenzale D, McKusick A, Kaplan MM. Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis. Gastroenterology 1994; 107: 266-70.
9. Leuschner U, Leuschner M, Sieratzki J, Kurtz W, Hübner K. Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study. Dig Dis Sci 1985; 30: 642-9.
10. Heuman DM. Hepatoprotective properties of ursodeoxycholic acid. Gastroenterology 1993; 104: 1865-9 [editorial].
11. Lim AG, Jazrawi RP, Northfield TC. The ursodeoxycholic acid story in primary biliary cirrhosis. Gut 1995; 37: 301-4.
12. Paumgartner G. Ursodeoxycholic acid treatment of primary biliary cirrhosis: potential mechanisms of action. In: Lindor KD, Heathcote EJ, Poupon R (Eds). Primary biliary cirrhosis: from pathogenesis to clinical treatment. Dordrecht: Kluwer Academic Publishers and Axcan Pharma, 1998.
13. Poupon RE, Balkau B, Eschwège E, Poupon R and the UDCA-PBC Study Group. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 1991; 324: 1548-54.
14. Poupon RE, Poupon R, Balkau B and the UDCA-PBC Study Group. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994; 330: 1342-7.
15. Heathcote EJ, Cauch-Dudek K, Walker V et al. The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1994; 19: 1149-56.
16. Lindor KD, Dickson ER, Baldus WP et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994; 106: 1284-90.
17. Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Dickson ER. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology 1996; 110: 1515-8.
18. Batts KP, Jorgensen RA, Dickson ER, Lindor KD. Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis. Am J Gastroenterol 1996; 91: 2314-7.
19. Lindor KD, Jorgensen RA, Therneau TM, Malinchoc M, Dickson ER. Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis. Mayo Clin Proc 1997; 72: 1137-40.
20. Combes B, Carithers RL, Maddrey WC et al. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1995; 22: 759-66.
21. Eriksson LS, Olsson R, Glauman H et al. Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. Scand J Gastroenterol 1997; 32: 179-86.
22. Turner IB, Myszor M, Mitchison HC, Bennett MK, Burt AD, James OFW. A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis. J Gastroenterol Hepatol 1994; 9: 162-8.
23. Vuoristo M, Färkkilä M, Karvonen A-L et al. A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid. Gastroenterology 1995; 108: 1470-8.
24. Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997; 113: 884-90.